Finance

Beta
Lists
603567:SHA
Heilongjiang ZBD Pharmaceutical Co Ltd
CNÂ¥7.00
+4.95%
(+0.33) 1D
Jun 5, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603567...
Open
CNÂ¥6.71
High
CNÂ¥7.09
Low
CNÂ¥6.71
Mkt. cap
6.59B
Avg. vol.
17.44M
Volume
18.62M
52-wk high
CNÂ¥13.48
52-wk low
CNÂ¥6.42
EPS
-CNÂ¥1.60
Shares outstanding
849.16M
No. of employees
2K
Open
CNÂ¥6.71
High
CNÂ¥7.09
Low
CNÂ¥6.71
Mkt. cap
6.59B
Avg. vol.
17.44M
Volume
18.62M
52-wk high
CNÂ¥13.48
52-wk low
CNÂ¥6.42
EPS
-CNÂ¥1.60
Shares outstanding
849.16M
No. of employees
2K
News stories
From sources across the web
About Heilongjiang ZBD Pharmaceutical Co Ltd
CEO-
Employees1.96K
FoundedOct 28, 1996
Headquarters-
SectorPharmaceutical industry
Websitezbdzy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
244.47M
204.78M
-120.85M
181.65M
Cost of goods sold
265.05M
206.91M
600.55M
180.99M
Cost of revenue
265.05M
206.91M
600.55M
180.99M
Research and development expenses
7.44M
8.75M
26.82M
8.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99.75M
99.80M
43.54M
71.31M
Operating expense
144.80M
137.83M
225.64M
83.84M
Total operating expenses
409.85M
344.75M
826.18M
264.83M
Operating income
-165.38M
-139.97M
-947.03M
-83.17M
Other non operating income
-14.36M
12.87M
-374.29M
-152.25M
EBT including unusual items
-201.18M
-350.54M
-1.16B
-226.54M
EBT excluding unusual items
-207.15M
-168.80M
-1.31B
-237.68M
Income tax expense
-46.96M
-55.10M
-168.17M
-45.60M
Effective tax rate
23.34%
15.72%
14.47%
20.13%
Other operating expenses
8.14M
-34.39M
40.92M
3.89M
Net income
-153.59M
-294.81M
-993.43M
-179.95M
Net profit margin
-62.82%
-143.97%
822.03%
-99.06%
Earnings per share
-
-
-
-
Interest and investment income
5.33M
137.59K
31.21M
-
Interest expense
-39.00M
-41.82M
-24.43M
-
Net interest expenses
-33.67M
-41.69M
6.78M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-125.16M
-101.46M
-905.32M
-41.46M
Gain or loss from assets sale
-
-
612.90K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer